Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Precision Biosciences (DTIL) Revenue (2018 - 2025)

Historic Revenue for Precision Biosciences (DTIL) over the last 8 years, with Q3 2025 value amounting to $13000.0.

  • Precision Biosciences' Revenue fell 9774.31% to $13000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $698000.0, marking a year-over-year decrease of 9907.05%. This contributed to the annual value of $68.7 million for FY2024, which is 4098.14% up from last year.
  • Latest data reveals that Precision Biosciences reported Revenue of $13000.0 as of Q3 2025, which was down 9774.31% from $18000.0 recorded in Q2 2025.
  • Precision Biosciences' 5-year Revenue high stood at $68.8 million for Q2 2021, and its period low was $13000.0 during Q3 2025.
  • For the 5-year period, Precision Biosciences' Revenue averaged around $13.6 million, with its median value being $7.4 million (2022).
  • As far as peak fluctuations go, Precision Biosciences' Revenue skyrocketed by 628265.31% in 2021, and later crashed by 9996.39% in 2025.
  • Over the past 5 years, Precision Biosciences' Revenue (Quarter) stood at $6.3 million in 2021, then skyrocketed by 67.19% to $10.6 million in 2022, then plummeted by 33.59% to $7.0 million in 2023, then crashed by 90.93% to $638000.0 in 2024, then plummeted by 97.96% to $13000.0 in 2025.
  • Its last three reported values are $13000.0 in Q3 2025, $18000.0 for Q2 2025, and $29000.0 during Q1 2025.